Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Kuller

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|April 12, 2002
A biologist's guide to synchrotron facilities: the BioSync web resourceAnne Kuller, Ward Fleri, Wolfgang F Bluhm, et al.
Proteome Science|December 17, 2011
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patientsPhillip Kim, Xinjun Liu, Tani Lee, et al.
Plos One|August 5, 2014
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational statusJeeyun Lee, Anjali Jain, Phillip Kim, et al.
Plos One|February 2, 2013
A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancersJeeyun Lee, Sung Kim, Phillip Kim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|April 12, 2002
A biologist's guide to synchrotron facilities: the BioSync web resourceAnne Kuller, Ward Fleri, Wolfgang F Bluhm, et al.
Proteome Science|December 17, 2011
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patientsPhillip Kim, Xinjun Liu, Tani Lee, et al.
Plos One|August 5, 2014
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational statusJeeyun Lee, Anjali Jain, Phillip Kim, et al.
Plos One|February 2, 2013
A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancersJeeyun Lee, Sung Kim, Phillip Kim, et al.
Pageof 1